US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.14

-0.0600-5.00%

Pre-market: 1.180.0400+3.51%08:04 EDT

Volume:600.85K

Turnover:690.81K

Market Cap:214.32M

PE:-0.93

High:1.21

Open:1.20

Low:1.12

Close:1.20

52wk High:3.65

52wk Low:0.8302

Shares:188.00M

Float Shares:116.00M

Volume Ratio:1.07

T/O Rate:0.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2237

EPS(LYR):-1.4501

ROE:-187.11%

ROA:-73.85%

PB:4.81

PE(LYR):-0.79

Loading ...

Overview Company News Filings

Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference

Analysts’ Top Healthcare Picks: Cullinan Management (CGEM), Neumora Therapeutics, Inc. (NMRA)

Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside

Neumora Therapeutics reports Q1 EPS (30c), consensus (31c)

Neumora Therapeutics Q1 EPS $(0.30) Beats $(0.33) Estimate

Benzinga Earnings

Neumora Therapeutics posts corporate presentation outlining neuroscience drug development pipeline

Neumora Q1 FY26 net loss narrows to $53.5 million

Neumora Therapeutics Inc: $147.1 Mln in Cash and Cash Equivalents Expected to Support Operations Into Q3 of 2027

THOMSON REUTERS

Neumora Therapeutics Inc - Net Loss of $53.5 Mln for Q1 2026

THOMSON REUTERS

Neumora Therapeutics Inc - Nmra-511 and Nmra-898 Clinical Data Expected in Second Half of 2026

THOMSON REUTERS

Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Neumora Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Neumora Therapeutics announces annual shareholder meeting

Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference

H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

Neumora Therapeutics management to meet with Piper Sandler

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA) and Sandoz Group Ltd (OtherSDZXF)

Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/NMRA/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.14,"timestamp":1789070400000,"preClose":1.2,"halted":0,"volume":600847,"hourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.14,"latestTime":"08:04 EDT","volume":50,"amount":59,"timestamp":1789128269685,"change":0.04,"changeRate":0.035088,"amplitude":0},"delay":0,"changeRate":-0.050000000000000044,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"Pre-Mkt","change":-0.06,"latestTime":"09-11 08:18:51 EDT","open":1.2,"high":1.21,"low":1.115,"amount":690807.8557198,"amplitude":0.079167,"askPrice":1.28,"askSize":200,"bidPrice":1.1,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-1.223678,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.14,"latestTime":"08:04 EDT","volume":50,"amount":59,"timestamp":1789128269685,"change":0.04,"changeRate":0.035088,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.14,"latestTime":"19:58 EDT","volume":8419,"amount":9600.7452,"timestamp":1789084687578,"change":0.01,"changeRate":0.008772,"amplitude":0.008772},"volumeRatio":1.0684889069815269,"impliedVol":0.1069,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":115999999,"roa":"-73.85%","roe":"-187.11%","lyrEps":-1.450067,"volumeRatio":1.0684889069815269,"shares":188000000,"dividePrice":0,"high":1.21,"amplitude":0.079167,"preClose":1.2,"low":1.115,"week52Low":0.83015,"pbRate":"4.81","week52High":3.65,"institutionHeld":0,"latestPrice":1.14,"committee":0.555556,"eps":-1.223678,"divideRate":0,"volume":600847,"delay":0,"ttmEps":-1.223678,"open":1.2,"prevYearClose":1.79,"prevWeekClose":1.31,"prevMonthClose":1.33,"prevQuarterClose":1.7,"fiveDayClose":1.38,"twentyDayClose":1.71,"sixtyDayClose":0.9145},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"NMRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.23,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-07","symbol":"NMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-03-30","symbol":"NMRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-11-06","symbol":"NMRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-06","symbol":"NMRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2026-09-10","current":-0.931618,"percent":0.809722,"low":-19.620035,"twenty":-8.492333,"median":-1.711218,"eighty":-1.07268,"high":-0.385538,"avg":-4.775026,"sd":4.907206,"marketCap":225475094},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-27","current":-0.501055,"twenty":-11.897527,"median":-6.552046,"eighty":-0.939895,"marketCap":129301288},{"date":"2025-07-03","current":-0.51497,"twenty":-11.882746,"median":-6.531197,"eighty":-0.932192,"marketCap":132892092},{"date":"2025-07-11","current":-0.664396,"twenty":-11.845391,"median":-6.513687,"eighty":-0.915408,"marketCap":171452797},{"date":"2025-07-18","current":-1.071809,"twenty":-11.813935,"median":-6.466558,"eighty":-0.901766,"marketCap":276588946},{"date":"2025-07-25","current":-1.435347,"twenty":-11.800172,"median":-6.430581,"eighty":-0.91143,"marketCap":370402741},{"date":"2025-08-01","current":-1.228506,"twenty":-11.772648,"median":-6.345689,"eighty":-0.913154,"marketCap":317025927},{"date":"2025-08-08","current":-1.05869,"twenty":-11.733327,"median":-6.279953,"eighty":-0.915408,"marketCap":266884071},{"date":"2025-08-15","current":-1.015014,"twenty":-11.717599,"median":-6.27111,"eighty":-0.917957,"marketCap":255873774},{"date":"2025-08-22","current":-1.053558,"twenty":-11.711701,"median":-6.248553,"eighty":-0.922507,"marketCap":265590500},{"date":"2025-08-29","current":-1.130648,"twenty":-11.697847,"median":-6.240161,"eighty":-0.927824,"marketCap":285023951},{"date":"2025-09-05","current":-1.047134,"twenty":-11.691098,"median":-6.234271,"eighty":-0.929873,"marketCap":263971046},{"date":"2025-09-12","current":-1.066407,"twenty":-11.688352,"median":-6.217154,"eighty":-0.931528,"marketCap":268829408},{"date":"2025-09-19","current":-1.00859,"twenty":-11.674168,"median":-6.167847,"eighty":-0.932308,"marketCap":254254320},{"date":"2025-09-26","current":-1.092103,"twenty":-11.654686,"median":-6.150338,"eighty":-0.934175,"marketCap":275307225},{"date":"2025-10-03","current":-1.143496,"twenty":-11.648787,"median":-6.138654,"eighty":-0.935832,"marketCap":288262860},{"date":"2025-10-10","current":-1.252707,"twenty":-11.625195,"median":-6.129234,"eighty":-0.937276,"marketCap":315793582},{"date":"2025-10-17","current":-1.143496,"twenty":-11.585874,"median":-6.098338,"eighty":-0.939018,"marketCap":288262860},{"date":"2025-10-24","current":-1.483976,"twenty":-11.573312,"median":-6.085275,"eighty":-0.940658,"marketCap":374093936},{"date":"2025-10-31","current":-1.882272,"twenty":-11.535481,"median":-6.072715,"eighty":-0.944448,"marketCap":474500101},{"date":"2025-11-07","current":-1.768195,"twenty":-11.493728,"median":-6.047595,"eighty":-0.950132,"marketCap":417819201},{"date":"2025-11-14","current":-1.902139,"twenty":-11.492838,"median":-5.97813,"eighty":-0.950743,"marketCap":449469716},{"date":"2025-11-21","current":-1.668791,"twenty":-11.473837,"median":-5.972235,"eighty":-0.95386,"marketCap":394330309},{"date":"2025-11-28","current":-1.583937,"twenty":-11.438475,"median":-5.963003,"eighty":-0.958453,"marketCap":374279615},{"date":"2025-12-05","current":-1.608686,"twenty":-11.3991,"median":-5.921482,"eighty":-0.963621,"marketCap":380127734},{"date":"2025-12-12","current":-1.488688,"twenty":-11.349949,"median":-5.869128,"eighty":-0.966191,"marketCap":351772572},{"date":"2025-12-19","current":-1.236978,"twenty":-11.209123,"median":-5.84706,"eighty":-0.976733,"marketCap":292294118},{"date":"2025-12-26","current":-1.301703,"twenty":-11.180579,"median":-5.82548,"eighty":-0.977791,"marketCap":307588578},{"date":"2026-01-02","current":-1.28732,"twenty":-10.823503,"median":-5.782265,"eighty":-0.97889,"marketCap":304189809},{"date":"2026-01-09","current":-1.675673,"twenty":-10.734234,"median":-5.771277,"eighty":-0.987831,"marketCap":395956567},{"date":"2026-01-16","current":-1.531839,"twenty":-10.632004,"median":-5.730809,"eighty":-0.990132,"marketCap":361968879},{"date":"2026-01-23","current":-1.510263,"twenty":-10.51228,"median":-5.690707,"eighty":-0.994023,"marketCap":356870726},{"date":"2026-01-30","current":-1.474305,"twenty":-10.431808,"median":-5.626838,"eighty":-0.999937,"marketCap":348373804},{"date":"2026-02-06","current":-1.409579,"twenty":-10.281677,"median":-5.512839,"eighty":-1.00602,"marketCap":333079344},{"date":"2026-02-13","current":-2.337313,"twenty":-10.17329,"median":-5.423912,"eighty":-1.009395,"marketCap":552299933},{"date":"2026-02-20","current":-2.502722,"twenty":-10.087087,"median":-5.390906,"eighty":-1.011964,"marketCap":591385774},{"date":"2026-02-27","current":-2.553064,"twenty":-9.944314,"median":-5.374404,"eighty":-1.018277,"marketCap":603281465},{"date":"2026-03-06","current":-2.157519,"twenty":-9.899493,"median":-5.330396,"eighty":-1.027437,"marketCap":509815323},{"date":"2026-03-13","current":-2.258203,"twenty":-9.891226,"median":-5.316643,"eighty":-1.03397,"marketCap":533606704},{"date":"2026-03-20","current":-1.848275,"twenty":-9.844641,"median":-2.553064,"eighty":-1.034185,"marketCap":436741793},{"date":"2026-03-27","current":-1.790741,"twenty":-9.769472,"median":-2.506318,"eighty":-1.034236,"marketCap":423146718},{"date":"2026-04-02","current":-1.605828,"twenty":-9.718546,"median":-2.484743,"eighty":-1.034286,"marketCap":380465575},{"date":"2026-04-10","current":-1.598144,"twenty":-9.645471,"median":-2.437997,"eighty":-1.035523,"marketCap":378645165},{"date":"2026-04-17","current":-1.536677,"twenty":-9.606931,"median":-2.340909,"eighty":-1.040518,"marketCap":364081890},{"date":"2026-04-24","current":-1.719486,"twenty":-9.518687,"median":-2.301354,"eighty":-1.04071,"marketCap":407394409},{"date":"2026-05-01","current":-1.904543,"twenty":-9.445953,"median":-2.229437,"eighty":-1.041995,"marketCap":451239547},{"date":"2026-05-08","current":-1.495876,"twenty":-9.432484,"median":-2.171903,"eighty":-1.047134,"marketCap":354414867},{"date":"2026-05-15","current":-1.618279,"twenty":-9.420361,"median":-2.157519,"eighty":-1.047134,"marketCap":359895509},{"date":"2026-05-22","current":-1.519703,"twenty":-9.409586,"median":-2.064027,"eighty":-1.047134,"marketCap":337972940},{"date":"2026-05-29","current":-1.544347,"twenty":-9.388035,"median":-2.022348,"eighty":-1.047134,"marketCap":343453582},{"date":"2026-06-05","current":-1.437557,"twenty":-9.385312,"median":-1.929745,"eighty":-1.050677,"marketCap":319704133},{"date":"2026-06-12","current":-1.48298,"twenty":-9.273547,"median":-1.902139,"eighty":-1.053558,"marketCap":329805954},{"date":"2026-06-18","current":-1.274697,"twenty":-9.262772,"median":-1.884704,"eighty":-1.052982,"marketCap":283484893},{"date":"2026-06-26","current":-1.258034,"twenty":-9.249303,"median":-1.881168,"eighty":-1.053558,"marketCap":279779208},{"date":"2026-07-02","current":-1.349679,"twenty":-9.177916,"median":-1.861064,"eighty":-1.05513,"marketCap":300160475},{"date":"2026-07-10","current":-1.374673,"twenty":-9.115941,"median":-1.805124,"eighty":-1.057685,"marketCap":305719002},{"date":"2026-07-17","current":-1.333016,"twenty":-9.073636,"median":-1.796333,"eighty":-1.060483,"marketCap":296454790},{"date":"2026-07-24","current":-1.299691,"twenty":-9.014102,"median":-1.790741,"eighty":-1.061679,"marketCap":289043420},{"date":"2026-07-31","current":-1.374673,"twenty":-8.975861,"median":-1.781172,"eighty":-1.06357,"marketCap":305719002},{"date":"2026-08-07","current":-1.366342,"twenty":-8.932776,"median":-1.776358,"eighty":-1.066407,"marketCap":303866160},{"date":"2026-08-14","current":-1.441324,"twenty":-8.783796,"median":-1.768195,"eighty":-1.066716,"marketCap":320541742},{"date":"2026-08-21","current":-1.338045,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"marketCap":284662306},{"date":"2026-08-28","current":-1.307133,"twenty":-8.561179,"median":-1.728093,"eighty":-1.072157,"marketCap":278085949},{"date":"2026-09-04","current":-1.192317,"twenty":-8.495819,"median":-1.715299,"eighty":-1.07274,"marketCap":253659481},{"date":"2026-09-10","current":-1.059837,"twenty":-8.492333,"median":-1.711218,"eighty":-1.07268,"marketCap":225475094}],"updateTime":1789129131563},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635405182","title":"Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2635405182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635405182?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May  12, 2026  (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that targ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293381/0/en/Neumora-Therapeutics-to-Participate-in-2026-RBC-Capital-Markets-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0708994859.HKD","NMRA","BK4581","BK4207","BK4588","XBI","LABU","LU0029874061.USD","HCSG","LU0310800379.SGD","BK4137","LU0128525929.USD","LU0128526141.USD","LU0029864427.USD","XLV","BK4007","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633108656","title":"Analysts’ Top Healthcare Picks: Cullinan Management (CGEM), Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633108656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633108656?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:40","pubTimestamp":1778190011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cullinan Management (CGEM) and Neumora Therapeutics,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cullinan-management-cgem-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cullinan-management-cgem-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM","BK4007","LU0029874061.USD","BK4588","XLV","BK4585","NMRA","BK4137","LU0128526141.USD","XBI","HCSG","BK4139","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633317318","title":"Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2633317318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633317318?lang=en_us&edition=fundamental","pubTime":"2026-05-08 03:15","pubTimestamp":1778181323,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on NMRA stock, giving a Buy rating on April 28. Myles Minter has given his B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-neumora-citing-compelling-risk-reward-ahead-of-key-navacaprant-readouts-and-broader-pipeline-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-neumora-citing-compelling-risk-reward-ahead-of-key-navacaprant-readouts-and-broader-pipeline-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633641121","title":"Neumora Therapeutics reports Q1 EPS (30c), consensus (31c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633641121","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633641121?lang=en_us&edition=fundamental","pubTime":"2026-05-07 23:39","pubTimestamp":1778168397,"startTime":"0","endTime":"0","summary":"“We focused on steady execution during the first quarter, highlighted by the full enrollment of the navacaprant KOASTAL-2 and -3 studies with more ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q1-eps-30c-consensus-31c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q1-eps-30c-consensus-31c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714980","title":"Neumora Therapeutics Q1 EPS $(0.30) Beats $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714980","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714980?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153452,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 28.57 percent increase over losses of $(0.42) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52361424/neumora-therapeutics-q1-eps-0-30-beats-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633604145","title":"Neumora Therapeutics posts corporate presentation outlining neuroscience drug development pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633604145","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633604145?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:04","pubTimestamp":1778151855,"startTime":"0","endTime":"0","summary":"Neumora outlined multiple near-term clinical catalysts across three franchises, with navacaprant Phase 3 KOASTAL-2 and KOASTAL-3 topline data expected in 2H 2026.Pipeline progress targets include NMRA-898 Phase 1 data in 2H 2026, NMRA-511 multiple-ascending-dose data in 2H 2026, NMRA-511 Phase 2 study start in 1Q 2027.Metabolic program NMRA-215 is slated to enter clinic in 1Q 2027.NMRA-511 Phase 1b readout highlighted tolerability with low discontinuations due to treatment-emergent adverse events of 2.5%, with efficacy signals in Alzheimer’s disease agitation including Cohen’s d effect size of 0.32-0.34 in NPI-AA ≥4 population at Week 6-8, rising to 0.51-0.64 in prespecified elevated-anxiety subgroup.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL3PDrm7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633614562","title":"Neumora Q1 FY26 net loss narrows to $53.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633614562","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633614562?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151827,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics posted a net loss of USD 53.5 million, narrowing from USD 68 million a year earlier, with loss per share improving to USD 0.3 from USD 0.42.R&D expense fell to USD 38.6 million from USD 52.2 million, due to reduced clinical trial costs and lower personnel-related costs.G&A expense dropped to USD 14.3 million from USD 18.8 million on lower personnel-related costs, while cash and cash equivalents slid to USD 147.1 million.KOASTAL-2 and -3 studies of navacaprant in major depressive disorder remain on track for a joint topline readout in Q2 2026, with clinical data for NMRA-511 in Alzheimer’s disease agitation and NMRA-898 in schizophrenia expected in 2H 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Ther","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL9scQSq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633829146","title":"Neumora Therapeutics Inc: $147.1 Mln in Cash and Cash Equivalents Expected to Support Operations Into Q3 of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2633829146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633829146?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA9PWCHN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633463741","title":"Neumora Therapeutics Inc - Net Loss of $53.5 Mln for Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633463741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633463741?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA9PWCHN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146877","title":"Neumora Therapeutics Inc - Nmra-511 and Nmra-898 Clinical Data Expected in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146877?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA9PWCHN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633414538","title":"Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633414538","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633414538?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"KOASTAL-2 and -3 studies evaluating navacaprant in major depressive disorder on track for joint topline readout in the second quarter of 2026 Progressing NMRA-511 in Alzheimer’s disease agitation and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289792/0/en/Neumora-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4007","AD","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633661019","title":"Neumora Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633661019","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633661019?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:28","pubTimestamp":1777926485,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Neumora Therapeutics Inc NMRA.OQ NMRA.O is expected to  show no change in quarterly revenue when it reports  resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H28V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781230","title":"Neumora Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781230","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781230?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:06","pubTimestamp":1776456363,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics annual shareholder meeting set for May 27, 2026, to be held virtually.Shareholders will vote on election of three Class III directors to serve until 2029.Ballot includes ratification of Ernst & Young as independent auditor for fiscal year 2026.Advisory votes scheduled on executive compensation, including preferred frequency for future say-on-pay votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL5XJWnm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625375676","title":"Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2625375676","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625375676?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473200,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., April  06, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc.(Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that targ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268343/0/en/Neumora-Therapeutics-to-Participate-in-25th-Annual-Needham-Virtual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007","LABU","XBI","BK4581","LU0029874061.USD","BK4137","BK4585","LU0128526141.USD","BK4588","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625673638","title":"H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625673638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625673638?lang=en_us&edition=fundamental","pubTime":"2026-04-06 17:35","pubTimestamp":1775468129,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Neumora Therapeutics, Inc. today and set a price target of $18.00. Tsao covers the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624023618","title":"Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624023618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624023618?lang=en_us&edition=fundamental","pubTime":"2026-04-04 22:50","pubTimestamp":1775314206,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and Anapty...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-neumora-therapeutics-inc-nmra-palisade-bio-pali-and-anaptysbio-anab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-neumora-therapeutics-inc-nmra-palisade-bio-pali-and-anaptysbio-anab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","XLV","BK4139","LABU","LU0029874061.USD","ANAB","LU0128526141.USD","BK4585","HCSG","PALI","BK4581","BK4007","XBI","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507791","title":"Neumora Therapeutics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624507791?lang=en_us&edition=fundamental","pubTime":"2026-04-02 22:37","pubTimestamp":1775140636,"startTime":"0","endTime":"0","summary":"Meeting to be held on April 6 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624569030","title":"Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA) and Sandoz Group Ltd (OtherSDZXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624569030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624569030?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:00","pubTimestamp":1775019616,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neumora Therapeutics, Inc. (NMRA) and Sandoz Group...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neumora-therapeutics-inc-nmra-and-sandoz-group-ltd-othersdzxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neumora-therapeutics-inc-nmra-and-sandoz-group-ltd-othersdzxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","XLV","LABU","LU0029874061.USD","LU0128526141.USD","BK4585","HCSG","BK4581","BK4007","XBI","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595552","title":"Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624595552?lang=en_us&edition=fundamental","pubTime":"2026-04-01 08:10","pubTimestamp":1775002225,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (($NMRA)) has held its Q4 earnings call. Read on for the main highlights of the call. Neumora Therapeutics’ latest earni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-maps-high-stakes-catalyst-road-ahead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-maps-high-stakes-catalyst-road-ahead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533152","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533152?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:50","pubTimestamp":1774968608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","LU0029874061.USD","BK4137","XLV","LABU","BK4588","GANX","HCSG","BK4585","BK4139","XBI","IVA","BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":95,"code":"91000000","status":"200"}]}}